This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Ichiro Mori, PhD
Director of Quality Assurance/CQO at NATiAS Inc.
Speaker

Profile

Dr. Mori joined NATiAS in 2021 and is a director of Quality Assurance/CQO. Prior to NATiAS, he has started his carrier as a medicinal chemist at Novartis, and moved to GSK and Pfizer as a director of chemistry department in the area of central nervous disease, cancer, and intestinal disease. He then moved to Kobe University as a professor working on drug discovery projects in the field of diabetes, cancer, and Alzheimer disease. He received M.S from Kyoto University and then Ph.D from Department of Chemistry at U.C. Berkeley in 1988.

Agenda Sessions

  • The Process Development for Blockmer™ Synthesis in Liquid-phase

    11:35